Veracyte, Inc., a leading cancer diagnostics company, announced that a new study published in JCO Precision Oncology shows that, among patients undergoing Active Surveillance (AS)...
Profluent, the AI-first protein design company, today debuted the OpenCRISPRTM initiative, releasing the world’s first open-source, AI-generated gene editor. With this launch, Profluent demonstrates the...
AIRS Medical Inc., a leading provider of AI-powered healthcare solutions, recently announced that the company has signed supply agreements in Germany and the United...
A Significant Milestone Towards Aiding Rare Diseases Companies Leverage Cutting-Edge Technology and Consulting Expertise to Elevate Patient Care
CustomerInsights.AI is pleased to announce a global strategic...
This approval helps address an urgent unmet need, with about half of people living with early-stage NSCLC experiencing disease recurrence following surgery, despite adjuvant...
Roche announced that its Elecsys pTau217 assay received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). This blood test, which is...
Charles River Laboratories International, Inc. announced the launch of Patholytix Foresight, a non-clinical artificial intelligence (AI) decision support tool developed in collaboration with Deciphex,...